Innovent Unveils Progress Across the General Biomedicine Pipeline at the 2025 ACR Annual Meeting The 2025 ACR Annual Meeting in San Francisco and nearby venues became a hub for researchers and industry leaders as Innovent Biologics, a global biopharmaceutical company, highlighted several milestones from its General Biomedicine Pipeline. The presentations underscored a commitment to advancing…